Recent studies have revealed that MRPL13 is abnormally expressed in several malignancies, such as breast cancer [18], gastric cancer [19], liver cancer [20], and lung cancer [21], and plays a significant role in driving malignant progression. This evidence concerns the gene MRPL13 and breast carcinoma.